Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 1 3Phase 2/3 2

Status

Recruiting 2

Sponsor Class

OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1NET 1Lymphoid 1Endocrine 1

Conditions

Pancreatic Neoplasms 1Disease 1Colonic Neoplasms 1

Interventions

Oxaliplatin 49Fluorouracil 46Capecitabine 41Cisplatin 36Gemcitabine 29Leucovorin 27Bevacizumab 21Drug Therapy 20Paclitaxel 15Folfox protocol 15Radiotherapy 14Irinotecan 14apatinib 11Neoadjuvant Therapy 11Docetaxel 11sintilimab 9S 1 (combination) 9Sorafenib 8Nivolumab 8Trastuzumab 7Surgical Procedures, Operative 7Magnetic Resonance Spectroscopy 7lenvatinib 6atezolizumab 6XELOX 6Cetuximab 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6tislelizumab 5pembrolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Positron Emission Tomography Computed Tomography × Gastrointestinal × Clear all
NCT07272772 2025-12-09

Colon Cancer Diagnosis With FAPI-PET Imaging

Turku University Hospital

Phase 2/3 Recruiting
100 enrolled
Gastrointestinal

Colonic Neoplasms

NCT07098598 2025-08-01

Pancreatic Cancer Diagnosis With FAPI-PET Imaging

Turku University Hospital

Phase 2/3 Recruiting
100 enrolled
Gastrointestinal

Disease, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡